Schellenberg Wittmer advised Boerhringer Ingelheim on the deal. Boehringer Ingelheim has acquired Saiba Animal Health AG, a company focused on the development of novel therapeutic medicines...
Boehringer Ingelheim’s Acquisition Of Saiba Animal Health AG
Boehringer Ingelheim’s Victory in First Zantac-Related Trial
King & Spalding secured a victory for Boehringer Ingelheim in the Circuit Court of Cook County, Illinois in the first trial regarding claims that its widely...
Boehringer Ingelheim’s CHF450 Million Acquisition of T3 Pharmaceuticals AG
Walder Wyss advised Boehringer Ingelheim in the transaction. Boehringer Ingelheim announced the acquisition of privately-held T3 Pharmaceuticals AG, a clinical stage Swiss biotech company, for an...
Boehringer Ingelheim Pharma’s Allegations of Abuse of Dominance
Trilegal successfully defends global pharmaceutical innovator Boehringer Ingelheim. The Competition Commission of India (CCI) has passed a final order and held that Boehringer Ingelheim Pharma GmbH...
Boehringer Ingelheim’s Establishing Shared Services Centre in Wroclaw
JDP Drapala & Partners advised Boehringer Ingelheim on the deal. As reported in CEE Legal Matter and in others online publications Boehringer Ingelheim established a shared services...
Boehringer Ingelheim’s Victory before Corte di Appello di Milano
IN BRIEF: Trevisan & Cuonzo, advised on the matter. Trevisan & Cuonzo advised Boehringer Ingelheim Corporation with a team including Donatella Capelli (IP&IT), Gabriele Cuonzo (Picture...